Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
48.77
-2.06 (-4.05%)
At close: Aug 28, 2026, 4:00 PM EDT
48.81
+0.04 (0.08%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Rapport Therapeutics Employees
Rapport Therapeutics had 84 employees as of December 31, 2025. The number of employees increased by 15 or 21.74% compared to the previous year.
Employees
84
Change (1Y)
15
Growth (1Y)
21.74%
Revenue / Employee
$238,095
Profits / Employee
-$1,632,857
Market Cap
2.34B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 84 | 15 | 21.74% |
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Vera Therapeutics | 361 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 305 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Kodiak Sciences | 141 |
| Mesoblast | 108 |
RAPP News
- 6 days ago - Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program - GlobeNewsWire
- 13 days ago - Rapport Therapeutics price target raised to $75 from $68 at Raymond James - TheFly
- 13 days ago - Rapport Therapeutics price target raised to $66 from $40 at H.C. Wainwright - TheFly
- 25 days ago - Rapport Therapeutics reports Q2 EPS ($1.19), consensus (99c) - TheFly
- 25 days ago - Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update - GlobeNewsWire
- 25 days ago - Rapport Therapeutics Earnings release: Q2 2026 - Filings
- 25 days ago - Rapport Therapeutics Quarterly report: Q2 2026 - Filings
- 25 days ago - Rapport Therapeutics Slides: Corporate presentation - Filings